Results 291 to 298 of about 3,746,725 (298)

Direct-Acting Antiviral Therapy Decreases Hepatocellular Carcinoma Recurrence Rate in Cirrhotic Patients With Chronic Hepatitis C

Liver International, 2017
Pierre-François Pradat, Radenne Sylvie, Fabien Zoulim   +2 more
exaly  

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Gastroenterology, 2018
Julia Dietz, Krzysztof Tomasiewicz, Peter Malfertheiner   +2 more
exaly  

Safety of Oral Direct Acting Antiviral Regimens for Chronic Hepatitis C in Real Life Conditions

Postgraduate Medicine, 2017
Jesus Castilla, Regina Juanbeltz, Ramón San Miguel   +2 more
exaly  

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Gastroenterology, 2019
Prasun Jalal, Maarouf A Hoteit, Anjana Pillai   +2 more
exaly  

Impact of Direct Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis

Journal of Hepatology, 2016
Ashley S Brown, Benjamin E Hudson, Graham R Foster   +2 more
exaly  

Lack of Evidence of an Effect of Direct-Acting Antivirals on the Recurrence of Hepatocellular Carcinoma: Data From Three ANRS Cohorts

Journal of Hepatology, 2016
exaly  

Direct-acting antivirals safe in elderly patients

Reactions Weekly, 2016
openaire   +1 more source

Direct-acting antivirals assessed by UK's MHRA

Reactions Weekly, 2017
openaire   +1 more source